Assessing a modified-AJCC TNM staging system in the New South Wales Cancer Registry, Australia

Abstract Background In 2017, the New South Wales Cancer Registry (NSWCR) participated in a project, supported by Cancer Australia, aiming to provide national stage data for melanoma, prostate, colorectal, breast, and lung cancers diagnosed in 2011. Simplified business rules based on the American Joi...

Full description

Bibliographic Details
Main Authors: Sheena Lawrance, Chau Bui, Vidur Mahindra, Maria Arcorace, Claire Cooke-Yarborough
Format: Article
Language:English
Published: BMC 2019-08-01
Series:BMC Cancer
Subjects:
Online Access:http://link.springer.com/article/10.1186/s12885-019-6062-x
_version_ 1818515845426446336
author Sheena Lawrance
Chau Bui
Vidur Mahindra
Maria Arcorace
Claire Cooke-Yarborough
author_facet Sheena Lawrance
Chau Bui
Vidur Mahindra
Maria Arcorace
Claire Cooke-Yarborough
author_sort Sheena Lawrance
collection DOAJ
description Abstract Background In 2017, the New South Wales Cancer Registry (NSWCR) participated in a project, supported by Cancer Australia, aiming to provide national stage data for melanoma, prostate, colorectal, breast, and lung cancers diagnosed in 2011. Simplified business rules based on the American Joint Committee for Cancer (AJCC) Tumour-Node-Metastasis (TNM) stage were applied to obtain Registry-Derived (RD) stage, defined as the best estimate of TNM stage at diagnosis using routine notifications available within cancer registries. RD-stage was compared with Degree of Spread (DoS), which has been recorded for all applicable cancers in NSWCR at a population-based level since 1972, and a summary AJCC-TNM stage group, which has been collected variably since 2006. For each of the five high incidence cancers, we compared the level of improvements RD-staging provided in terms of completeness and accuracy (alignment to more clinically relevant AJCC-TNM) over DoS. Methods For each of the five cancers, stage data were extracted from NSWCR pre- and post- RD-staging to compare data completeness across all three staging systems. The alignment between DoS/RD-stage and AJCC-TNM was compared, as were the expected and observed cross-tabulated frequency distributions using a subset of NSWCR data. To determine differences between use of DoS, RD-stage, and AJCC-TNM in an epidemiological analysis, we compared survival models developed from each of the three stage variables. Results We found RD-staging provided greatest stage data completeness and alignment to AJCC-TNM for prostate cancers, followed by breast, then melanoma and lung cancers. For colorectal cancer, summary stage from DoS was confirmed as an equivalent surrogate staging system to both AJCC-TNM and RD-stage. Conclusions This analysis provides an evidence-based approach that can be used to inform decision-making for resource planning and potential implementation of a new stage data field in population-based cancer registries.
first_indexed 2024-12-11T00:34:10Z
format Article
id doaj.art-5cf9710e935944eaabb47ad43a633f1b
institution Directory Open Access Journal
issn 1471-2407
language English
last_indexed 2024-12-11T00:34:10Z
publishDate 2019-08-01
publisher BMC
record_format Article
series BMC Cancer
spelling doaj.art-5cf9710e935944eaabb47ad43a633f1b2022-12-22T01:27:13ZengBMCBMC Cancer1471-24072019-08-0119111110.1186/s12885-019-6062-xAssessing a modified-AJCC TNM staging system in the New South Wales Cancer Registry, AustraliaSheena Lawrance0Chau Bui1Vidur Mahindra2Maria Arcorace3Claire Cooke-Yarborough4Cancer Institute NSWCancer Institute NSWCancer Institute NSWCancer Institute NSWCancer Institute NSWAbstract Background In 2017, the New South Wales Cancer Registry (NSWCR) participated in a project, supported by Cancer Australia, aiming to provide national stage data for melanoma, prostate, colorectal, breast, and lung cancers diagnosed in 2011. Simplified business rules based on the American Joint Committee for Cancer (AJCC) Tumour-Node-Metastasis (TNM) stage were applied to obtain Registry-Derived (RD) stage, defined as the best estimate of TNM stage at diagnosis using routine notifications available within cancer registries. RD-stage was compared with Degree of Spread (DoS), which has been recorded for all applicable cancers in NSWCR at a population-based level since 1972, and a summary AJCC-TNM stage group, which has been collected variably since 2006. For each of the five high incidence cancers, we compared the level of improvements RD-staging provided in terms of completeness and accuracy (alignment to more clinically relevant AJCC-TNM) over DoS. Methods For each of the five cancers, stage data were extracted from NSWCR pre- and post- RD-staging to compare data completeness across all three staging systems. The alignment between DoS/RD-stage and AJCC-TNM was compared, as were the expected and observed cross-tabulated frequency distributions using a subset of NSWCR data. To determine differences between use of DoS, RD-stage, and AJCC-TNM in an epidemiological analysis, we compared survival models developed from each of the three stage variables. Results We found RD-staging provided greatest stage data completeness and alignment to AJCC-TNM for prostate cancers, followed by breast, then melanoma and lung cancers. For colorectal cancer, summary stage from DoS was confirmed as an equivalent surrogate staging system to both AJCC-TNM and RD-stage. Conclusions This analysis provides an evidence-based approach that can be used to inform decision-making for resource planning and potential implementation of a new stage data field in population-based cancer registries.http://link.springer.com/article/10.1186/s12885-019-6062-xCancer RegistriesCancerOncologyEpidemiologyRegistryStage
spellingShingle Sheena Lawrance
Chau Bui
Vidur Mahindra
Maria Arcorace
Claire Cooke-Yarborough
Assessing a modified-AJCC TNM staging system in the New South Wales Cancer Registry, Australia
BMC Cancer
Cancer Registries
Cancer
Oncology
Epidemiology
Registry
Stage
title Assessing a modified-AJCC TNM staging system in the New South Wales Cancer Registry, Australia
title_full Assessing a modified-AJCC TNM staging system in the New South Wales Cancer Registry, Australia
title_fullStr Assessing a modified-AJCC TNM staging system in the New South Wales Cancer Registry, Australia
title_full_unstemmed Assessing a modified-AJCC TNM staging system in the New South Wales Cancer Registry, Australia
title_short Assessing a modified-AJCC TNM staging system in the New South Wales Cancer Registry, Australia
title_sort assessing a modified ajcc tnm staging system in the new south wales cancer registry australia
topic Cancer Registries
Cancer
Oncology
Epidemiology
Registry
Stage
url http://link.springer.com/article/10.1186/s12885-019-6062-x
work_keys_str_mv AT sheenalawrance assessingamodifiedajcctnmstagingsysteminthenewsouthwalescancerregistryaustralia
AT chaubui assessingamodifiedajcctnmstagingsysteminthenewsouthwalescancerregistryaustralia
AT vidurmahindra assessingamodifiedajcctnmstagingsysteminthenewsouthwalescancerregistryaustralia
AT mariaarcorace assessingamodifiedajcctnmstagingsysteminthenewsouthwalescancerregistryaustralia
AT clairecookeyarborough assessingamodifiedajcctnmstagingsysteminthenewsouthwalescancerregistryaustralia